GB2127689B - Calcitonin inhalation compositions - Google Patents

Calcitonin inhalation compositions

Info

Publication number
GB2127689B
GB2127689B GB08326436A GB8326436A GB2127689B GB 2127689 B GB2127689 B GB 2127689B GB 08326436 A GB08326436 A GB 08326436A GB 8326436 A GB8326436 A GB 8326436A GB 2127689 B GB2127689 B GB 2127689B
Authority
GB
United Kingdom
Prior art keywords
calcitonin
inhalation compositions
inhalation
compositions
calcitonin inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08326436A
Other versions
GB2127689A (en
GB8326436D0 (en
Inventor
Moise Azria
Thomas Cavanak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838320865A external-priority patent/GB8320865D0/en
Priority claimed from GB838322528A external-priority patent/GB8322528D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GB08326436A priority Critical patent/GB2127689B/en
Publication of GB8326436D0 publication Critical patent/GB8326436D0/en
Publication of GB2127689A publication Critical patent/GB2127689A/en
Application granted granted Critical
Publication of GB2127689B publication Critical patent/GB2127689B/en
Priority to CY146689A priority patent/CY1466A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB08326436A 1982-10-05 1983-10-03 Calcitonin inhalation compositions Expired GB2127689B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB08326436A GB2127689B (en) 1982-10-05 1983-10-03 Calcitonin inhalation compositions
CY146689A CY1466A (en) 1982-10-05 1989-07-21 Galenic compositions comprising calcitonin and their use

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB8228390 1982-10-05
GB8236928 1982-12-30
GB838320865A GB8320865D0 (en) 1983-08-03 1983-08-03 Organic compounds
GB838322528A GB8322528D0 (en) 1983-08-22 1983-08-22 Organic compounds
GB08326436A GB2127689B (en) 1982-10-05 1983-10-03 Calcitonin inhalation compositions

Publications (3)

Publication Number Publication Date
GB8326436D0 GB8326436D0 (en) 1983-11-02
GB2127689A GB2127689A (en) 1984-04-18
GB2127689B true GB2127689B (en) 1986-07-09

Family

ID=27516489

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08326436A Expired GB2127689B (en) 1982-10-05 1983-10-03 Calcitonin inhalation compositions

Country Status (2)

Country Link
CY (1) CY1466A (en)
GB (1) GB2127689B (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
JPS61267528A (en) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd Transnasal calcitonin agent containing absorbefacient
JPS61194034A (en) * 1985-02-25 1986-08-28 Teijin Ltd Powdery composition for transnasal administration
JPH0651637B2 (en) 1985-03-28 1994-07-06 エーザイ株式会社 Peptide adsorption prevention composition
NL8701143A (en) * 1986-05-27 1987-12-16 Sandoz Ag PHARMACEUTICAL PREPARATIONS.
AT396870B (en) * 1986-08-07 1993-12-27 Sandoz Ag Process for the production of a pharmaceutical formulation for the nasal administration of serotonin antagonists
EP0327756B1 (en) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
NZ228285A (en) * 1988-03-11 1991-08-27 Teikoku Seiyaku Kk Pharmaceutical composition comprising a polypeptide and adapted for intravaginal administration
US5514365A (en) * 1988-10-11 1996-05-07 Schiapparelli Salute S.P.A. Pharmaceutical compositions comprising calcitonin for intranasal administration
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
IT8920486A0 (en) * 1989-05-12 1989-05-12 Isf Spa PHARMACEUTICAL COMPOSITIONS.
JPH078806B2 (en) * 1990-08-16 1995-02-01 旭化成工業株式会社 Nasal emulsion containing calcitonin
IT1242019B (en) * 1990-11-20 1994-02-02 Ripari Gero Ist Farm Biolog CALCITONIN-BASED AQUEOUS PHARMACEUTICAL COMPOSITIONS, TO BE ADMINISTERED NASAL.
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5306482A (en) * 1991-04-09 1994-04-26 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
US5227152A (en) * 1991-04-09 1993-07-13 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats
DE4117078A1 (en) * 1991-05-25 1992-11-26 Boehringer Ingelheim Kg METHOD FOR PRODUCING THERAPEUTICALLY APPLICABLE AEROSOLS
DE4222647A1 (en) * 1991-07-15 1993-01-21 Sandoz Ag PEPTIDE PREPARATIONS
GR1001447B (en) * 1992-12-08 1993-12-30 Ron Poulenk Rorer Anonymos Emp Pharmaceutical products for the endonosal administration of caltcitonine.
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US5514670A (en) * 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
DE69512083T2 (en) 1994-11-17 2000-03-30 Alza Corp DEVICE FOR INCREASING THE ACTIVE SUBSTANCE ADMINISTRATION BY ELECTRO TRANSPORT
DE726075T1 (en) * 1995-02-08 1996-12-12 Therapicon Srl Non-inorganic pharmaceutical saline solutions for endonasal administration
US5759583A (en) * 1995-08-30 1998-06-02 Syntex (U.S.A.) Inc. Sustained release poly (lactic/glycolic) matrices
ATE429240T1 (en) * 1999-01-29 2009-05-15 Esperanza Peptide Ltd BUCCAL DELIVERY SYSTEM FOR PROTEIN CONTAINING MEDICATIONS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB763168A (en) * 1953-12-31 1956-12-12 Abbott Lab Inhalant preparation
GB1213985A (en) * 1967-03-29 1970-11-25 Ransomes Sims & Jefferies Ltd Improvements in combine harvesters
GB1354526A (en) * 1971-04-19 1974-06-05 Armour Pharma Preparation for obtaining diuresis in animals
MX3864E (en) * 1975-05-27 1981-08-26 Syntex Corp A PROCESS TO PREPARE THE CRYSTALLINE COMPOUND 6-FLUIRO-11B 21-DIHIROXI-16 17-ISOPROPILIDENDIOXIPREGNA-1 4-DIEN-3 20-DIONA
GB1592513A (en) * 1977-10-28 1981-07-08 Okido Y Multipurpose tooth cleaner

Also Published As

Publication number Publication date
GB2127689A (en) 1984-04-18
GB8326436D0 (en) 1983-11-02
CY1466A (en) 1989-07-21

Similar Documents

Publication Publication Date Title
GB2127689B (en) Calcitonin inhalation compositions
GB2132889B (en) Oral compositions
IL69892A0 (en) Pharmaceutical compositions comprising calcitonin
GB8320828D0 (en) Respirator
GB2127291B (en) Compositions containing cisplatinum
GB2116564B (en) Calcitonin derivatives
GB8310276D0 (en) Ester-heterocycle compositions
DE3372291D1 (en) Compositions
PT76898A (en) Cementiferous compositions
GB8314542D0 (en) Medical compositions
GB8316766D0 (en) Paint-finishing composition
GB8324200D0 (en) Composition
GB2129685B (en) Anti-haemophilic compositions
GB2131296B (en) Fungicidal compositions
GB8302374D0 (en) Nasal pharmaceutical compositions
GB8328709D0 (en) Respirators
GB8328717D0 (en) Oral compositions
GB2116563B (en) Calcitonin derivatives
GB2120942B (en) Salbutamol compositions
ZA83673B (en) Nasal pharmaceutical compositions
GB2126897B (en) Herbicidal compositions
GB8305191D0 (en) Composition
GB8306242D0 (en) Herbicidal compositions
GB2115283B (en) Herbicidal composition
GB2131694B (en) Herbicidal compositions

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PE20 Patent expired after termination of 20 years